PTEN acts on the phosphoinositide 3-kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) pathway and is one of the most commonly disrupted tumor suppressors in human cancer [46]. The gene discussed is PTEN; the disease is neoplasm.